[go: up one dir, main page]

NL2000374A1 - Bereiding van gamma-aminozuren met een affiniteit voor het alfa-2-delta-eiwit. - Google Patents

Bereiding van gamma-aminozuren met een affiniteit voor het alfa-2-delta-eiwit.

Info

Publication number
NL2000374A1
NL2000374A1 NL2000374A NL2000374A NL2000374A1 NL 2000374 A1 NL2000374 A1 NL 2000374A1 NL 2000374 A NL2000374 A NL 2000374A NL 2000374 A NL2000374 A NL 2000374A NL 2000374 A1 NL2000374 A1 NL 2000374A1
Authority
NL
Netherlands
Prior art keywords
affinity
alpha
preparation
amino acids
gamma amino
Prior art date
Application number
NL2000374A
Other languages
English (en)
Other versions
NL2000374C2 (nl
Inventor
Margaret Claire Evans
Lloyd Charles Franklin
Lorraine Michelle Murtagh
Thomas Norman
Allen Pearlman Bruce
James Edward Saenz
Niamh Josephine Willis
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NL2000374A1 publication Critical patent/NL2000374A1/nl
Application granted granted Critical
Publication of NL2000374C2 publication Critical patent/NL2000374C2/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30Preparation of optical isomers
    • C07C227/32Preparation of optical isomers by stereospecific synthesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/19Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/002Nitriles (-CN)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/005Amino acids other than alpha- or beta amino acids, e.g. gamma amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/005Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NL2000374A 2005-12-21 2006-12-13 Bereiding van gamma-aminozuren met een affiniteit voor het alfa-2-delta-eiwit. NL2000374C2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75283905P 2005-12-21 2005-12-21
US75283905 2005-12-21

Publications (2)

Publication Number Publication Date
NL2000374A1 true NL2000374A1 (nl) 2007-06-25
NL2000374C2 NL2000374C2 (nl) 2010-02-09

Family

ID=37903526

Family Applications (1)

Application Number Title Priority Date Filing Date
NL2000374A NL2000374C2 (nl) 2005-12-21 2006-12-13 Bereiding van gamma-aminozuren met een affiniteit voor het alfa-2-delta-eiwit.

Country Status (28)

Country Link
US (2) US20070141684A1 (nl)
EP (2) EP1973867A1 (nl)
JP (1) JP2009520492A (nl)
KR (1) KR20080068932A (nl)
CN (1) CN101341117A (nl)
AP (1) AP2008004485A0 (nl)
AR (1) AR058559A1 (nl)
AU (1) AU2006327872A1 (nl)
BR (1) BRPI0620467A2 (nl)
CA (1) CA2633358A1 (nl)
CR (1) CR10080A (nl)
DO (1) DOP2006000286A (nl)
EA (1) EA200801393A1 (nl)
EC (1) ECSP088551A (nl)
GT (1) GT200600524A (nl)
IL (1) IL191840A0 (nl)
MA (1) MA30139B1 (nl)
ME (1) ME00005B (nl)
NL (1) NL2000374C2 (nl)
NO (1) NO20082989L (nl)
NZ (1) NZ568971A (nl)
PE (1) PE20071169A1 (nl)
RS (1) RS20080279A (nl)
TN (1) TNSN08272A1 (nl)
TW (1) TW200736201A (nl)
UY (1) UY30031A1 (nl)
WO (1) WO2007072159A1 (nl)
ZA (1) ZA200804780B (nl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010012698A (es) * 2008-05-21 2011-03-15 Sandoz Ag Proceso para la hidrolisis enzimatica estereoselectiva del ester del acido 5-metil-3-nitro-metil-hexanoico.
MX2012013274A (es) 2010-05-21 2013-05-28 Chemilia Ab Novedosos derivados de la pirimidina.
FR2966734B1 (fr) * 2010-10-29 2014-07-18 Max Rombi Composition comprenant au moins une enzyme proteolytique pour son utilisation pour empecher la synthese des triglycerides
JP5886411B2 (ja) 2011-03-24 2016-03-16 ノビガ・リサーチ・エービーNoviga Research AB 新規のピリミジン誘導体
CN102249833B (zh) * 2011-05-27 2013-12-11 中国科学院化学研究所 一种制备手性γ-氨基酸及其衍生物的方法
WO2017155025A1 (ja) * 2016-03-10 2017-09-14 第一三共株式会社 酵素による光学分割を用いた光学活性吉草酸誘導体の製造方法
CN108192932B (zh) * 2017-12-26 2020-09-29 上海皓元生物医药科技有限公司 一种手性醇的酶催化制备方法
CN112877219A (zh) * 2021-01-29 2021-06-01 江西科技师范大学 一种高浓度胆固醇培养基及其制备方法和应用
CN119462461B (zh) * 2024-12-06 2025-11-04 万华化学集团股份有限公司 一种维生素a异构化的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
US5618710A (en) 1990-08-03 1997-04-08 Vertex Pharmaceuticals, Inc. Crosslinked enzyme crystals
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
WO2000035296A1 (en) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Improved release of medicament active agents from a chewing gum coating
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
ES2317839T3 (es) * 1999-06-10 2009-05-01 Warner-Lambert Company Llc Acidos 3-propil gamma-aminobutiricos monosustituidos.
US6642398B2 (en) * 1999-06-10 2003-11-04 Warner-Lambert Company Mono-and disubstituted 3-propyl gamma-aminobutyric acids
WO2004054566A1 (en) 2002-12-13 2004-07-01 Warner-Lambert Company Llc Pregabalin derivatives for the treatment of fibromyalgia and other disorders
UA82292C2 (uk) * 2004-04-14 2008-03-25 Пфайзер Продактс Инк. Спосіб стереоселективного біоперетворення аліфатичних динітрилів в ціанокарбонові кислоти (варіанти)

Also Published As

Publication number Publication date
EP2017259A3 (en) 2011-04-13
NZ568971A (en) 2010-04-30
IL191840A0 (en) 2008-12-29
AP2008004485A0 (en) 2008-06-30
JP2009520492A (ja) 2009-05-28
CA2633358A1 (en) 2007-06-28
BRPI0620467A2 (pt) 2011-11-16
KR20080068932A (ko) 2008-07-24
CR10080A (es) 2008-07-10
GT200600524A (es) 2007-12-03
WO2007072159A1 (en) 2007-06-28
TNSN08272A1 (fr) 2009-10-30
TW200736201A (en) 2007-10-01
DOP2006000286A (es) 2007-07-31
AR058559A1 (es) 2008-02-13
EP2017259A2 (en) 2009-01-21
NO20082989L (no) 2008-09-19
ECSP088551A (es) 2008-07-30
RS20080279A (sr) 2009-07-15
WO2007072159B1 (en) 2008-08-21
CN101341117A (zh) 2009-01-07
AU2006327872A1 (en) 2007-06-28
US20070141684A1 (en) 2007-06-21
ME00005B (me) 2010-06-10
NL2000374C2 (nl) 2010-02-09
PE20071169A1 (es) 2007-11-30
EA200801393A1 (ru) 2009-12-30
US20090299093A1 (en) 2009-12-03
UY30031A1 (es) 2007-07-31
EP1973867A1 (en) 2008-10-01
MEP0708A (xx) 2010-02-10
MA30139B1 (fr) 2009-01-02
ZA200804780B (en) 2009-05-27

Similar Documents

Publication Publication Date Title
CY2019041I2 (el) Τροποποιημενα αντισωματα εναντι il-23
DK1492761T3 (da) Aminosyrer med affinitet til alpha-2-delta-proteinet
EP2206727A4 (en) ON THE OSTEOCLAST-RELATED PROTEIN Siglec-15 AIMING ANTIBODY
WO2007117564A3 (en) Clay-binding peptides and methods of use
WO2008070135A3 (en) Methods of treating systemic lupus erythematosus
CU23872B1 (es) Anticuerpos antagonistas dirigidos contra el péptido relacionado con el gen de calcitonina
NL1031539C2 (nl) Bicyclische [3.1.0] heteroarylamiden als type 1 glycinetransportremmers.
WO2007060117A3 (de) Chimäre keratinbindende effektorproteine
IL205398A0 (en) New antibodies specific of the ?? - amyloid peptides and their uses as diagnostic agents or drugs
NL1028397A1 (nl) Werkwijze voor automatisch bepalen van het sagittale vlak.
NL1031359A1 (nl) Werkwijzen en systemen voor het bewaken van tumorbelasting.
CL2007002619A1 (es) Compuestos derivados de 3-aza-biciclo[4.1.0]heptano; composicion farmaceutica; y uso en el tratamiento de la depresion.
NL1027115A1 (nl) Aminozuren met affiniteit voor het alfa-2-delta-proteïne.
NL2000374A1 (nl) Bereiding van gamma-aminozuren met een affiniteit voor het alfa-2-delta-eiwit.
NL1033229A1 (nl) Modulair ondersteuningsorgaan voor het overdekken van oppervlakken.
EP1904845A4 (en) IMPROVED RESULTS AND APPLICATION OF COMPARISON EXAMPLES OF PROTEIN EXPRESSIONS
AT504330B1 (de) Beschichtung hydrophiler oberflächen mit s-schicht-proteinen
EP1884510A4 (en) N-SUBSTITUTED PHENYLACETAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
NL1031705A1 (nl) Aminozuurderivaten.
NL1028535A1 (nl) Werkwijzen en systemen voor het ijken van medische beeldvormingssystemen.
NL1028646A1 (nl) Inrichting voor het inspecteren van metalen oppervlakken.
NL1032887A1 (nl) Stekkerdoos voor voertuig.
DE502006002739D1 (de) Kraftfahrzeugkarosserie
NL1032737C2 (nl) Systeem en werkwijze voor fotolithografie in het vervaardigen van halfgeleiders.
NL1031939A1 (nl) Werkwijze voor fotolithografie bij het vervaardigen van een halfgeleider.

Legal Events

Date Code Title Description
AD1A A request for search or an international type search has been filed
RD2N Patents in respect of which a decision has been taken or a report has been made (novelty report)

Effective date: 20091208

PD2B A search report has been drawn up
V1 Lapsed because of non-payment of the annual fee

Effective date: 20110701